Cancer progression provides clues about the nature, behaviour, and aggressiveness of cancer that can be accessed by clinico-pathological markers such as tumour size, grade, stage, lymph node status, and hormone receptor status, which are used to measure the severity of a patient’s cancer. Here, NR4A1 is linked to neoplasm.